Table 1.
Pharmacological mechanisms | Clinical symptoms |
---|---|
Decreased saliva production | Xerostomia |
Dysmotility of the lower esophageal sphincter | Gastro-esophageal reflux (or, rarely, dysphagia) |
Decreased gastric secretion, emptying and motility | Delayed absorption of medication, upper abdominal discomfort |
Disturbed fluid secretion and absorption | Constipation |
Abnormal bowel motility, increased resting contractile tone in the | Straining, incomplete bowel evacuation, bloating, abdominal |
small and large intestinal circular muscles, and sphincter dysfunction | distension, constipation |
Increased amplitudes of non-propulsive segmental bowel contractions | Spasm, abdominal cramps and pain, stasis of luminal contents, and hard dry stool |
Constriction of sphincter of Oddi | Biliary colic, epigastric discomfort, and pain |
Increased anal sphincter tone and impaired reflex relaxation during rectal distension | Evacuation disorders |
Diminished intestinal, pancreatic, and biliary secretion | Hard, dry stools |
Abnormal bowel motility, increased fermentation and meteorism, opioid-induced hyperalgesia | Chronic visceral pain |
Central effects of opioids | Nausea and vomiting, anorexia |
Notes: Adapted from: Springer International Publishing AG; Drugs; Opioid-induced bowel dysfunction: pathophysiology and management; 72(14); 2012; 1847–1865; Brock C, Olesen SS, Olesen AE, Frøkjaer JB, Andresen T, Drewes AM; Copyright © Springer International Publishing AG 2012; with kind permission of Springer Science+Business Media.12